SVFC~~~~~~~IntelliCell BioSciences Receives US Patent for its Stem Cell Extraction Technology
NEW YORK, June 13, 2013 /PRNewswire via COMTEX/ -- IntelliCell BioSciences, Inc. ("Company") (SVFC) announces that it has been notified by the US Patent office that its patent for stem cell extraction technology has been published. IntelliCell's proprietary patented method for deriving blood vessel originated vascular cells from adipose (fat) tissue by use of ultrasonic cavitation has been made official. This technology involves an innovative mechanical method for the separation of stromal vascular fraction cells from adipose (fat) tissue, without the use of enzymes. Vascular cells derived by IntelliCell's proprietary method are potentially useful in bringing the promise of regenerative medicine to many therapeutic and aesthetic procedures. Investors can access the published patent at the US Patent website by entering the patent # 8,440,440. Link to patent website: http://patft.uspto.gov/netahtml/PTO/srchnum.htm
IntelliCell's Chairman and CEO, Dr. Steven Victor, stated "Our Company is very pleased to announce today that with the publishing of our patent, our technology is now protected and we expect our international patent publication in a short time."
About IntelliCell BioSciences, Inc.
IntelliCell BioSciences is a Regenerative Medicine company developing novel technologies that address the regenerative, curative and preventative conditions of disease states with high unmet clinical needs. The Company has several patent-pending applications including the patent that was recently published, an industry unique method of obtaining autologous stromal vascular fraction cells (SVF) cells from the vasculature surrounding adipose tissue containing adult stem cells and a robust population of regenerative healing cells. The Company is also pioneering the development of autologous and allogeneic cells from living and non-living tissue donors for research purposes. IntelliCell is planning a series of in-human clinical studies with top tier universities for the treatment of osteoarthritis, multiple sclerosis, lower limb ischemic wounds, and gum regeneration in the oral cavity as well as medical aesthetics. The Company has developed a first in class cGTP cellular processing facility in New York City, purpose built and designed to be fully integrated into an ambulatory surgery center.
Forward-Looking Statements
Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "will reach," "will change," "will soon," "should," "could," "would," "may," "can" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.
Contacts:Anna Rhodes, IntelliCell BioSciences, Inc. Phone: (646) 576-8710 Email: arhodes@intellicellbiosciences.com
Melissa Diaz, South Street Media, Inc. Phone: (917) 937-8968 Email: info@southstreetmedia.com
SOURCE IntelliCell BioSciences, Inc.
http://rt.prnewswire.com/rt.gif?NewsItemId=NE...d=20130613
www.prnewswire.com
SVFC~~~~~~~IntelliCell BioSciences Receives US Patent for
Top 10 Most Recent News Articles
Northern Jet Names Veteran Matthew Harris as CEO
Fresh Leadership at Northern Jet Well, if you didn’t see this coming, you’ve been snoozing on the tarmac. Northern Jet, no stranger to the skies after three decades, just roped in Matthew Harris as their new CEO from October 2, 2026. They're pulling in this hotshot with more than 25 years riding the turbulence of private aviation. And listen to this: his marching...
Continue Reading
Navigating Holiday Sweets: Healthy Balancing Acts
In the middle of the sweet madness that is the holiday season, Crispy Green and Dr. Nicole Avena are playing guide to families drowning in sugar. This isn't just a once-a-year Halloween headache; we're starting that sugar spiral early and letting it ride until the New Year approaches. It's an all-hands-on-deck situation if families want to dodge that sugar overload. Why...
Continue Reading
Pushing for National Liver Cancer Awareness in 2026
The Urgency of Liver Cancer Awareness Death doesn’t wait, does it? When liver cancer is the villain in question, every moment becomes precious because this beast doesn’t roar until it’s too late. Here we are in 2026, staring at nearly 31,000 annual deaths in the U.S. alone. But hope flickers with a new congressional resolution aiming to slap a bright spotlight on...
Continue Reading
TA Services Strengthens U.S.-Mexico Freight Operations
TA Services Moves Boldly Across Borders If ever there was a time to play the logistics chessboard like a champ, it's now, and TA Services just slammed the board with a solid move. They've grabbed Carmen Pacheco Transportation and Interload Forwarding, two family-run operations with some real muscle in North American logistics. This isn't a small-time maneuver; they've...
Continue Reading
IWP and VYRE Unveil 'The Plug' for VBNGtv Content
Bringing Capital and Content Under One Roof There's something in the air as Itibari-Waynne & Partners (IWP) team up with the VYRE Network to crank out a fresh slate of content for VYRE Business News Global (VBNGtv). This partnership ain't just another splash in the buzzy world of digital media; it's like merging Wall Street with Hollywood. IWP, prepping to go full...
Continue ReadingROKFORM’s Signal Card: A Wallet Tracker for All
The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...
Continue Reading
NYSE Texas Redefines the U.S. Capital Markets Landscape
NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...
Continue Reading
Skandia's Soundproofing Kit Expands to Brazil's Skies
Soundproofing Takes Off in Brazil Skandia has just pulled off a neat trick, earning the nod from Brazil's National Civil Aviation Agency (ANAC) for their King Air soundproofing kit. That means quieter skies ahead for operators of the King Air 200 and 300 series in Brazil. This is no small feat, folks; it's like finally getting that coveted backstage pass after years of...
Continue Reading
JiMMYBAR! Expands Creatine Market with Target Launch
JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...
Continue Reading
Community Banks Missing $106B Lending Opportunity?
A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...
Continue ReadingTop 5 Most Recently Viewed Articles
Pernod Ricard USA’s Elevated Strategy for Thriving Growth
Pernod Ricard USA's Transformation in Market Strategy Pernod Ricard USA has rolled out a significant transformation of its Route-to-Market (RTM) strategy aimed at fostering sustainable growth across its extensive portfolio. This change is a crucial step in enhancing the company's market position, expanding its reach within the competitive beverage industry. Leadership and...
Continue Reading
Longboard Pharmaceuticals Launches Phase 3 Study for Bexicaserin
Alright, let’s slice into this. Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH) is stepping up with its global Phase 3 DEEp SEA Study—an ambitious clinical trial centered on bexicaserin aimed at tackling the nasty seizures associated with Dravet syndrome. This isn’t just some side project; it's a significant leap for a company that's planted its flag firmly in the...
Continue Reading
Rutini Wines Enters New Era with Juan Pablo Murgia
Rutini Wines Welcomes Juan Pablo Murgia Known for its prestigious history, Rutini Wines is embarking on an exciting new journey with the remarkably talented Juan Pablo Murgia. Rutini Wines, one of the oldest and most respected wineries in Argentina, is making headlines with the impressive appointment of Juan Pablo Murgia as the new Head of Winemaking. With this...
Continue Reading
Analyst Predicts Bright Future for Nvidia Amid Challenges
Analyst Insights on Nvidia's Market Position Vivek Arya, an analyst at BofA Securities, has reaffirmed a Buy rating for Nvidia Corp (NASDAQ: NVDA) and set a price target of $165. This target corresponds to a calendar 2025E price-to-earnings (PE) ratio of 42x, which fits within Nvidia's historical PE range of 21x to 67x. Growth Potential Despite Market Headwinds Arya’s...
Continue Reading
Pudgy Penguins Expands Retail Reach with Walgreens Launch
Pudgy Penguins Expands Retail Reach with Walgreens Launch Pudgy Penguins has exciting news for its fans! The beloved brand has made a significant leap in its retail growth with the launch of its Pudgy Toys at 2,000 Walgreens locations across the country. This expansion not only enhances accessibility for fans but also reflects the brand's continued push into major U.S....
Continue Reading